Citations

Showing 10 of 108104 citations.

Book Review: Oxford Textbook of Sleep Disorders
Dredla, Brynn K.

Mayo Clinic

Journal of Clinical Neurophysiology | September 6, 2018 | Volume: 36 | Issue: 1 | Pages: 85-85

10.1097/wnp.0000000000000504 Get It

Basilar Thumb Arthritis: The Utility of Suture-Button Suspensionplasty
DeGeorge, Brent R. , Chawla, Sagar , Elhassan, Bassem T. , Chawla, Sagar S, Elhassan, Bassem T. , Kakar, Sanjeev

Mayo Clinic

HAND | September 6, 2018 | Volume: 14 | Issue: 1 | Pages: 66-72

10.1177/1558944718798850 | PMID 30188195 Get It

Background: We sought to compare the functional outcomes, radiographic outcomes, and complications of trapeziectomy and flexor carpi radialis (FCR) to abductor pollicis longus (APL) side-to-side tendon transfer with or without suture-button suspensionplasty for thumb basilar joint arthritis. Methods: Patients treated with and without suture-button suspensionplasty were compared over a 6-year period. Data were reviewed for complications and functional outcomes, including grip and pinch strength, range of motion, and visual analog scale (VAS) pain scores. Plain radiographs were independently reviewed at initial presentation and at final follow-up, including proximal phalanx length, trapezial space height, and trapezial height ratio. Results: Seventy thumb arthroplasties were performed in 70 patients. Trapeziectomy with FCR-APL side-to-side tendon transfer was performed in 39 patients, and trapeziectomy with FCR-APL side-to-side tendon transfer with suture-button suspensionplasty was performed in 31 patients. Mean length of follow-up was 28.4 ± 3.9 and 23.8 ± 2.6 months, respectively. Postoperative grip, oppositional and appositional pinch strength, and VAS pain scores improved compared with preoperative values, but were not significantly different based on suture-button suspensionplasty. Percentage decline in trapezial space ratio was significantly different between groups at 36.7% and 20.4% for procedures with and without suture-button suspensionplasty, respectively indicating that the trapezial space was better maintained within the suture suspension cohort. The incidence of postoperative complications, including surgical site infection, paresthesias, reoperation, complex regional pain syndrome, and symptomatic subsidence, was not significantly different between groups. Conclusions: Trapeziectomy with FCR to APL side-to-side tendon transfer with and without suture-button suspensionplasty results in comparable improvement in pain, grip strength, and functional parameters. Suture-button suspensionplasty results in significantly greater preservation of trapezial space.
A Capacity Allocation Planning Model for Integrated Care and Access Management
Deglise‐Hawkinson, Jivan, Huschka, Todd R., Kaufman, David L. , Oyen, Mark P. Van , Huschka, Todd, Helm, Jonathan Eugene

Mayo Clinic

Production and Operations Management | September 6, 2018 | Volume: 27 | Issue: 12 | Pages: 2270-2290

10.1111/poms.12941 | PMID 30930608 Get It

The prevailing first‐come‐first‐served approach to outpatient appointment scheduling ignores differing urgency levels, leading to unnecessarily long waits for urgent patients. In data from a partner healthcare organization, we found in some departments that urgent patients were inadvertently waiting longer for an appointment than non‐urgent patients. This study develops a capacity allocation optimization methodology that reserves appointment slots based on urgency in a complicated, integrated care environment where multiple specialties serve multiple types of patients. This optimization reallocates network capacity to limit access delays (indirect waiting times) for initial and downstream appointments differentiated by urgency. We formulate this problem as a queueing network optimization and approximate it via deterministic linear optimization to simultaneously smooth workloads and guarantee access delay targets. In a case study of our industry partner we demonstrate the ability to (i) reduce urgent patient mean access delay by 27% with only a 7% increase in mean access delay for non‐urgent patients, and (ii) increase throughput by 31% with the same service levels and overtime.
Micro-RNAS Regulate Metabolic Syndrome-induced Senescence in Porcine Adipose Tissue-derived Mesenchymal Stem Cells through the P16/MAPK Pathway
Eirin, Alfonso , Zhu, Xingen , Hickson, LaTonya J. , Wijnen, André J. van , Lerman, Lilach O. , van Wijnen, Andre J , Hickson, LaTonya J , Eirin, Alfonso , Meng, Yu , Zhu, X.-Y., Tang, Hui Ru , Lerman, Amir

Mayo Clinic

Cell Transplantation | September 6, 2018 | Volume: 27 | Issue: 10 | Pages: 1495-1503

10.1177/0963689718795692 | PMID 30187775 Get It

Mesenchymal stem cells (MSCs) constitute an important repair system, but may be impaired by exposure to cardiovascular risk factors. Consequently, adipose tissue-derived MSCs from pigs with the metabolic syndrome (MetS) show decreased vitality. A growing number of microRNAs (miRNAs) are recognized as key modulators of senescence, but their role in regulating senescence in MSC in MetS is unclear. We tested the hypothesis that MetS upregulates in MSC expression of miRNAs that can serve as post-transcriptional regulators of senescence-associated (SA) genes. MSCs were collected from swine abdominal adipose tissue after 16 weeks of Lean or Obese diet ( n = 6 each). Next-generation miRNA sequencing (miRNA-seq) was performed to identify miRNAs up-or down-regulated in MetS-MSCs compared with Lean-MSCs. Functional pathways of SA genes targeted by miRNAs were analyzed using gene ontology. MSC senescence was evaluated by p16 and p21 immunoreactivity, H2AX protein expression, and SA-β-Galactosidase activity. In addition, gene expression of p16, p21, MAPK3 (ERK1) and MAPK14, and MSC migration were studied after inhibition of SA-miR-27b. Senescence biomarkers were significantly elevated in MetS-MSCs. We found seven upregulated miRNAs, including miR-27b, and three downregulated miRNAs in MetS-MSCs, which regulate 35 SA genes, particularly MAPK signaling. Inhibition of miR-27b in cultured MSCs downregulated p16 and MARP3 genes, and increased MSC migration. MetS modulates MSC expression of SA-miRNAs that may regulate their senescence, and the p16 pathway seems to play an important role in MetS-induced MSC senescence.
Temperature and humidity affect the incidence of hand, foot, and mouth disease: a systematic review of the literature – a report from the International Society of Dermatology Climate Change Committee
Coates, Sarah J. , Davis, Mark D.P. , Andersen, Louise K.

Mayo Clinic

International Journal of Dermatology | September 6, 2018 | Volume: 58 | Issue: 4 | Pages: 388-399

10.1111/ijd.14188 | PMID 30187452 Get It

AbstractHand, foot, and mouth disease (HFMD) is an enterovirus‐mediated condition that predominantly affects children under 5 years of age. The tendency for outbreaks to peak in warmer summer months suggests a relationship between HFMD and weather patterns. We reviewed the English‐language literature for articles describing a relationship between meteorological variables and HFMD. Seventy‐two studies meeting criteria were identified. A positive, statistically significant relationship was identified between HFMD cases and both temperature (61 of 67 studies, or 91.0%, reported a positive relationship) [CI 81.8–95.8%,P = 0.0001] and relative humidity (41 of 54 studies, or 75.9%) [CI 63.1–85.4%,P = 0.0001]. No significant relationship was identified between HFMD and precipitation, wind speed, and/or sunshine. Most countries reported a single peak of disease each year (most commonly early Summer), but subtropical and tropical climate zones were significantly more likely to experience a bimodal distribution of cases throughout the year (two peaks a year; most commonly late spring/early summer, with a smaller peak in autumn). The rising global incidence of HFMD, particularly in Pacific Asia, may be related to climate change. Weather forecasting might be used effectively in the future to indicate the risk of HFMD outbreaks and the need for targeted public health interventions.
Protein modeling and clinical description of a novel in‐frame GLB1 deletion causing GM1 gangliosidosis type II
Richter, John E. , Zimmermann, Michael T. , Blackburn, Patrick R. , Mohammad, Ahmed N. , Klee, Eric W. , Pollard, Laura, Macmurdo, Colleen, Atwal, Paldeep S. , Caulfield, Thomas R. , Atwal, Paldeep S , Caulfield, Thomas R , Zimmermann, Michael T

Mayo Clinic

Molecular Genetics & Genomic Medicine | September 6, 2018 | Volume: 6 | Issue: 6 | Pages: 1229-1235

10.1002/mgg3.454 | PMID 30187681 Get It

AbstractBackgroundBeta‐galactosidase‐1 (GLB1) is a lysosomal hydrolase that is responsible for breaking down specific glycoconjugates, particularly GM1 (monosialotetrahexosylganglioside). Pathogenic variants in GLB1 cause two different lysosomal storage disorders: GM1 gangliosidosis and mucopolysaccharidosis type IVB. In GM1 gangliosidosis, decreased β‐galactosidase‐1 enzymatic activity leads to the accumulation of GM1 gangliosides, predominantly within the CNS. We present a 22‐month‐old proband with GM1 gangliosidosis type II (late‐infantile form) in whom a novel homozygous in‐frame deletion (c.1468_1470delAAC, p.Asn490del) in GLB1 was detected.MethodsWe used an experimental protein structure of β‐galactosidase‐1 to generate a model of the p.Asn490del mutant and performed molecular dynamic simulations to determine whether this mutation leads to altered ligand positioning compared to the wild‐type protein. In addition, residual mutant enzyme activity in patient leukocytes was evaluated using a fluorometric assay.ResultsMolecular dynamics simulations showed the deletion to alter the catalytic site leading to misalignment of the catalytic residues and loss of collective motion within the model. We predict this misalignment will lead to impaired catalysis of β‐galactosidase‐1 substrates. Enzyme assays confirmed diminished GLB1 enzymatic activity (~3% of normal activity) in the proband.ConclusionsWe have described a novel, pathogenic in‐frame deletion of GLB1 in a patient with GM1 gangliosidosis type II.
Maternal Obesity Affects Cardiac Remodeling and Recovery in Women with Peripartum Cardiomyopathy
Davis, Esa M. , Ewald, Gregory A. , Givertz, Michael M. , Rajagopalan, Navin , Cooper, Leslie T. , Felker, G. Michael , Bozkurt, Biykem , Hanley‐Yanez, Karen , Halder, Indrani, McTiernan, Charles F. , McNamara, Dennis M. , Investigators, on behalf of the IPAC, Kleet, Audrey , Cooper, Leslie T , Briller, Joan Ellen , Drazner, Mark H. , Investigators, on behalf of the IPAC

Mayo Clinic

American Journal of Perinatology | September 5, 2018 | Volume: 36 | Issue: 05 | Pages: 476-483

10.1055/s-0038-1669439 | PMID 30184556 Get It

Objective To examine the association between maternal obesity on left ventricular (LV) size and recovery in women with peripartum cardiomyopathy (PPCM). Study Design This was a prospective analysis of 100 women enrolled within 13 weeks of PPCM diagnosis and followed for a year in the Investigation of Pregnancy Associated Cardiomyopathy study. Adiposity was defined by standard body mass index (BMI) definitions for under/normal weight, overweight, and obesity. Demographic, clinical, and biomarker variables were compared across weight categories. Outcomes LV end-diastolic diameter (LVEDD) and ejection fraction were measured at entry, 6, and 12 months postpartum. Multivariable regression models examined the relationship between adiposity, LV size, and leptin levels with cardiac recovery at 6 and 12 months postpartum. Results Obese and nonobese women had similar LV dysfunction at entry. Obese women had greater LV size and less LV recovery at 6 and 12 months postpartum. BMI was positively associated with leptin and ventricular diameter. Greater BMI at entry remained associated with less ventricular recovery at 6 months (p = 0.02) in adjusted race-stratified models. LVEDD at entry predicted lower ejection fraction at 6 months (p < 0.001) and similarly at 12 months. Conclusion Obese women with PPCM had greater cardiac remodeling, higher leptin levels, and diminished cardiac recovery.
Assessing clinical outcomes following liver transplantation in intrahepatic cholangiocarcinoma and mixed hepatocellular carcinoma-cholangiocarcinoma patients: The Mayo Clinic experience.
DeLeon, Thomas, Lee, David D. , Girardo, Marlene , Rosen, Charles B. , Moss, Adyr A. , Mathur, Amit K. , Harnois, Denise M. , Aqel, Bashar , Rizvi, Sumera, Mody, Kabir , Lee, David D , Salomao, Marcela , Heimbach, Julie K. , Aqel, Bashar A. , Sonbol, Mohamad Bassam , Kosiorek, Heidi , Borad, Mitesh J.

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e16114-e16114

10.1200/jco.2018.36.15_suppl.e16114 Get It

Feasibility and clinical value of circulating tumor DNA testing in patients with gastroesophageal adenocarcinoma.
Mody, Kabir , Iqbal, Madiha , Kasi, Pashtoon Murtaza

Mayo Clinic

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e16045-e16045

10.1200/jco.2018.36.15_suppl.e16045 Get It